BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16970801)

  • 1. Heparanase induces tissue factor expression in vascular endothelial and cancer cells.
    Nadir Y; Brenner B; Zetser A; Ilan N; Shafat I; Zcharia E; Goldshmidt O; Vlodavsky I
    J Thromb Haemost; 2006 Nov; 4(11):2443-51. PubMed ID: 16970801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase, tissue factor, and cancer.
    Nadir Y; Vlodavsky I; Brenner B
    Semin Thromb Hemost; 2008 Mar; 34(2):187-94. PubMed ID: 18645924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
    Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
    Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase procoagulant effects and inhibition by heparins.
    Nadir Y; Brenner B
    Thromb Res; 2010 Apr; 125 Suppl 2():S72-6. PubMed ID: 20434010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparanase, heparin and the coagulation system in cancer progression.
    Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
    Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase coagulation and cancer progression.
    Nadir Y; Brenner B
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII.
    Nadir Y; Brenner B; Fux L; Shafat I; Attias J; Vlodavsky I
    Haematologica; 2010 Nov; 95(11):1927-34. PubMed ID: 20634491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase procoagulant activity in cancer progression.
    Nadir Y; Brenner B
    Thromb Res; 2016 Apr; 140 Suppl 1():S44-8. PubMed ID: 27067977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase multiple effects in cancer.
    Nadir Y; Brenner B
    Thromb Res; 2014 May; 133 Suppl 2():S90-4. PubMed ID: 24862152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
    Ilan N; Elkin M; Vlodavsky I
    Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase in the Coagulation System.
    Nadir Y
    Adv Exp Med Biol; 2020; 1221():771-784. PubMed ID: 32274737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase Level in the Microcirculation as a Possible Modulator of the Metastatic Process.
    Nevo N; Ghanem S; Crispel Y; Tatour M; Cohen H; Kogan I; Ben-Arush M; Nadir Y
    Am J Pathol; 2019 Aug; 189(8):1654-1663. PubMed ID: 31128083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
    Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
    Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
    Vlodavsky I; Ilan N; Naggi A; Casu B
    Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applications.
    Vlodavsky I; Elkin M; Ilan N
    Rambam Maimonides Med J; 2011 Jan; 2(1):e0019. PubMed ID: 23908791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparanase procoagulant activity.
    Nadir Y; Brenner B
    Thromb Res; 2012 Apr; 129 Suppl 1():S76-9. PubMed ID: 22682139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase: Historical Aspects and Future Perspectives.
    Khanna M; Parish CR
    Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of heparanase inhibitor on tissue factor overexpression in platelets and endothelial cells induced by anti-β2-GPI antibodies.
    Capozzi A; Riitano G; Recalchi S; Manganelli V; Costi R; Saccoliti F; Pulcinelli F; Garofalo T; Misasi R; Longo A; Di Santo R; Sorice M
    J Thromb Haemost; 2021 Sep; 19(9):2302-2313. PubMed ID: 34107171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell heparanase controls tumor invasion and immune surveillance.
    Putz EM; Mayfosh AJ; Kos K; Barkauskas DS; Nakamura K; Town L; Goodall KJ; Yee DY; Poon IK; Baschuk N; Souza-Fonseca-Guimaraes F; Hulett MD; Smyth MJ
    J Clin Invest; 2017 Jun; 127(7):2777-2788. PubMed ID: 28581441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.
    Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T
    J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.